Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Med Chem ; 48(4): 1237-43, 2005 Feb 24.
Article in English | MEDLINE | ID: mdl-15715490

ABSTRACT

3-(3-Cyclopentyloxy-4-methoxy-benzyl)-8-isopropyl-adenine V11294 (1) has been identified as a lead structure, which selectively inhibits human lung PDE4 (436 nM) and is also active in a number of in vitro and in vivo models of inflammation. Here we describe the synthesis and pharmacology of a series of highly potent 8-[(benzyloxy)methyl]-substituted analogues, with potencies in the range 10-300 nM. In addition, several compounds showed interesting PDE4 subtype specificities, for example, the 3-thienyl derivative 5v, which showed 6-10 nM potency at PDE4B, D3, and D5 and a 20- to 200-fold selectivity over A and D2, respectively.


Subject(s)
3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitors , Adenine/analogs & derivatives , Adenine/chemical synthesis , 3',5'-Cyclic-AMP Phosphodiesterases/chemistry , Adenine/chemistry , Cyclic Nucleotide Phosphodiesterases, Type 4 , Humans , Isoenzymes/antagonists & inhibitors , Isoenzymes/chemistry , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...